Ballentine Partners’s Unity Biotechnology UBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-57,046
| Closed | -$83.9K | – | 949 |
|
|
2024
Q3 | $83.9K | Buy |
+57,046
| New | +$83.9K | ﹤0.01% | 813 |
|
|
2021
Q4 | – | Sell |
-3,106
| Closed | -$93K | – | 485 |
|
|
2021
Q3 | $93K | Hold |
3,106
| – | – | ﹤0.01% | 418 |
|
|
2021
Q2 | $144K | Hold |
3,106
| – | – | 0.01% | 412 |
|
|
2021
Q1 | $186K | Buy |
+3,106
| New | +$186K | 0.01% | 383 |
|